What's happening at Entrada Therapeutics? Entrada is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible.
Our Endosomal Escape Vehicle (EEV™)-therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Through this proprietary, versatile and modular approach, Entrada is advancing a robust development portfolio of RNA- and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others.
Our lead oligonucleotide programs are in development for the potential treatment of people living with Duchenne who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1.
We are a tight-knit team of experts and leaders in both therapeutic development and rare diseases and are excited to grow and attract colleagues who are ready to join a high-energy, dedicated team that likes to get things done and dramatically improve the lives of patients and their families.
You want to join a high growth organization where your expertise directly shapes how scientific data is communicated internally and externally. You thrive in a collaborative and fast paced environment that requires strategic thinking, strong project management, and attention to detail. You look forward to learning the science behind Entrada’s platforms and pipeline and translating complex data into clear, accurate, and compelling scientific materials.
The OpportunityThe Director, Scientific Communications Lead will report directly into the Senior Vice President of Medical Affairs and will play an integral role in supporting Entradas portfolio in the neuromuscular and ocular space. This leader will guide the creation and execution of the medical affairs publication and scientific communications strategy. They will also develop the scientific communications plan, which includes the scientific platform, the medical education plan, the evidence generation plan, and the publications and congress plan.
As an internal medical affairs resource, this leader will bring or develop subject matter expertise in neuromuscular and ocular diseases and will work closely with internal partners to ensure scientific accuracy and consistency. They will oversee the design and delivery of internal and external training programs that strengthen understanding across key teams.
They will collaborate with medical affairs therapeutic area leads such as corporate affairs, clinical development, commercial, regulatory, and legal teams to shape strategic messaging and support cross functional execution
Responsibilities- Ensure the development and execution of publication, congress, training, scientific communication and medical education strategy across multiple platforms (conventional, digital, congress).
- Conduct literature reviews and gap analyses to identify data needs, inform strategy, and guide development of scientific communication tactics.
- Ensure creation of high quality, scientifically accurate, and compliant deliverables including slide decks, disease state materials, manuscript summaries, program specific FAQs, congress summaries, advisory board materials, training materials and other internal and external resources.
- Develop program specific scientific materials such as mechanism of disease or action graphics, data summary decks, and templates for company wide use.
- Provide writing and editorial support for abstracts, posters, manuscripts, and other publications, including conducting literature searches and preparing annotated summaries for internal teams.
- Oversee congress activities including content development for Discovery/Research and Medical Affairs presence, abstract coverage, congress summaries, and all related deliverables in collaboration with Corporate Communications, Investor Relations, and Competitive Intelligence.
- Lead publication planning activities including cross functional coordination, management of review and approval processes for external and field based materials, tracking of company or investigator led publications, and ensuring adherence to publication and scientific exchange compliance requirements including GPP3, ICMJE, and Sunshine Act guidance.
- Provide project management support for Scientific Communications including maintenance of slide libraries and repositories, version control, process design and improvement, and implementation of innovative approaches such as digital tools and publication metrics tracking.
- Lead medical and scientific messaging for medical affairs and ensuring these messages are aligned across all forms of scientific, field and corporate messaging.
- Partner with and manage vendor(s) to lead the execution of the scientific communications plan overseeing medical writing agencies including project initiation, execution, and closing; working with authors on submissions to congresses, journals etc, managing revisions, and budget.
- Collaborate with cross-functional teams/colleagues to develop evidence generation, publication and congress activities to ensure insight sharing and alignment across teams, and efficient execution of strategies and tactics
- Support market access efforts by developing appropriate medical materials and supportive documents and by providing medical expertise as required to internal and external stakeholders.
At Entrada, our passion for science, our devotion to patients and our values drives our behavior:
- Humanity - We genuinely care about patients and about one another.
- Tenacity - We are relentless and persistent in the pursuit of developing therapies for patients.
- Creativity - We are creative problem solvers.
- Collaboration - We are more than the sum of our parts.
- Curiosity - We have a growth mindset and push conventional thought and theory.
To thrive on our team, you will need to come with:
- Must have an advanced medical degree (MD, DO, or equivalent), PharmD or PhD.
- Experience in rare diseases, launch experience, and vendor management experience are advantages.
- 8+ years of medical affairs experience in the Pharmaceutical/Biotechnology industry
- Experience in neuromuscular disease and Duchenne’s Muscular Dystrophy a plus
- Proven success in a fast paced, entrepreneurial, smaller company environment is highly desired.
- Proven experience in working collaboratively and cross functionally across the enterprise field medical teams ,corporate affairs clinical development, commercial, sales, market access and other key functions and demonstrated ability to inform and shape company/product strategy.
- Demonstrated understanding of laws, regulations, standards, and guidance governing the conduct of publications.
- Understanding of relevant GCP, ICH and FDA/ EMA regulations.
- Ability to travel approximately 20% of the time both domestically and internationally, as determined by business needs.
- This role follows a hybrid working model, with office attendance 2-3 days per week minimum at the Entrada Therapeutics Headquarters in Boston, MA.
At Entrada Therapeutics, we understand that compensation and total rewards are a major consideration when exploring a new opportunity. We believe in transparency and equity and are committed to sharing salary ranges for every position, along with insight into our compensation philosophy, in accordance with certain state requirements in the United States and fostering a fair and open environment at the onset.
But we also know it is more than just pay. When you join Entrada, you’ll be part of a mission-driven team with access to comprehensive health, dental and vision coverage; life and disability insurance; with a 401(k) match. We pride ourselves on offering competitive benefits that empower our employees and reflect the value of their contributions – offering paid, gender-inclusive parental leave, holistic support for your health and well-being, education reimbursement, discretionary time off and commuting benefits aligned to your working model. If you find yourself working from our office in Boston’s Seaport District, this puts you steps away from some of the best the city has to offer.
“Our approach to compensation is grounded in transparency, equity and performance for the unique contributions each person brings. At Entrada, we know that meaningful work deserves meaningful reward — and we view compensation as one way we show appreciation for the collaboration, curiosity and commitment that drive our mission forward.”
— Kerry Robert, SVP of People
The salary for this opportunity ranges from $225,000-$253,000. The final base compensation offered will depend on several considerations which include but may not be limited to a candidate’s skills, competencies, experience and other job-related factors permitted by law. The final salary offered may fall outside of this range.
Equal Opportunity Employer
Entrada Therapeutics is an equal opportunity employer. Qualified candidates will receive consideration for employment without regard to race, color, religion, national origin, gender, sexual orientation, gender identity or expression, age, mental or physical disability, and genetic information, marital status, citizenship status, military status, protected veteran status or any other category protected by law.
Third Party Staffing Agencies
Entrada does not accept unsolicited resumes from any source other than directly from candidates. For the protection of all parties involved in the recruiting process, resumes will only be accepted from recruiters/agencies if a signed agreement is in place at the inception of the recruiting effort and authorized for a specified position. Unsolicited resumes sent to Entrada from recruiters/agencies do not constitute any type of relationship between the recruiter/agency and Entrada and do not obligate Entrada to pay fees if we hire from those resumes.
Entrada Therapeutics is an equal opportunity employer. Qualified candidates will receive consideration for employment without regard to race, color, religion, national origin, gender, sexual orientation, gender identity or expression, age, mental or physical disability, and genetic information, marital status, citizenship status, military status, protected veteran status or any other category protected by law.
Third Party Staffing AgenciesEntrada does not accept unsolicited resumes from any source other than directly from candidates. For the protection of all parties involved in the recruiting process, resumes will only be accepted from recruiters/agencies if a signed agreement is in place at the inception of the recruiting effort and authorized for a specified position. Unsolicited resumes sent to Entrada from recruiters/agencies do not constitute any type of relationship between the recruiter/agency and Entrada and do not obligate Entrada to pay fees if we hire from those resumes.
Privacy StatementEntrada Therapeutics, Inc. (the “Entrada,” “we,” “us,” or “our”) respects your privacy and we want you to be familiar with how we collect, use, share, or otherwise process, your Personal Information. Please reference our privacy statement here to understand how and when your data is being used.
Top Skills
Entrada Therapeutics Boston, Massachusetts, USA Office
6 Tide St, Boston, MA, United States, 02210
Similar Jobs
What you need to know about the Boston Tech Scene
Key Facts About Boston Tech
- Number of Tech Workers: 269,000; 9.4% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Thermo Fisher Scientific, Toast, Klaviyo, HubSpot, DraftKings
- Key Industries: Artificial intelligence, biotechnology, robotics, software, aerospace
- Funding Landscape: $15.7 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Summit Partners, Volition Capital, Bain Capital Ventures, MassVentures, Highland Capital Partners
- Research Centers and Universities: MIT, Harvard University, Boston College, Tufts University, Boston University, Northeastern University, Smithsonian Astrophysical Observatory, National Bureau of Economic Research, Broad Institute, Lowell Center for Space Science & Technology, National Emerging Infectious Diseases Laboratories



